Marina Konopleva

2 ta ish

The University of Texas MD Anderson Cancer Center

1. Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia

   Courtney D. DiNardo, Keith W. Pratz, Vinod Pullarkat +13

   Maqola20182 iqtibos

   ABIABI:AkademIndex/2026.other.312643

2. An inhibitor of oxidative phosphorylation exploits cancer vulnerability

   Jennifer R. Molina, Yuting Sun, Marina Protopopova +63

   Maqola20182 iqtibos

   ABIABI:AkademIndex/2026.other.340855